Characterization of gene expression associated with both the AcrAB/TolC system and the membrane permeability, in Salmonella spp isolates with and without gyrA mutation;Caracterización de la expresión de genes asociados con el sistema AcrAB/TolC y la permeabilidad de membrana en aislados de Salmonella spp. con y sin mutación en gyrA

Revista Espanola de Quimioterapia

Volumn 27, Issue 4, 2014, Pages 239-243

  Galiana, Antonio ^a   Sánchez Guillén, Laura ^a   Rodríguez, Juan Carlos ^b,c   Cremades, Rosa ^a   Santibañez, Miguel ^d   Ferrari, Rafaela ^a   Ruiz García, Montserrat ^a   López, Pilar ^a   Royo, Gloria ^a,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ACRB GENE; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION; GYRA GENE; MARA GENE; MEMBRANE PERMEABILITY; MUTATIONAL ANALYSIS; NONHUMAN; OMPF GENE; POLYMERASE CHAIN REACTION; RAMA GENE; REGULATOR GENE; SALMONELLA; SOXS GENE; WILD TYPE;

EID: 84942435586     PISSN: 02143429     EISSN: 19889518     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bhardwaj AK, Mohanty P. Bacterial efflux pumps involved in multidrug resistance and their Inhibitors: rejuvinating the antimicrobial chemotherapy. Recent Pat Antiinfect Drug Discov 2012; 7:73-89.
2. Baucheron S, Chaslus-Dancla E, Cloeckaert A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J Antimicrob Chemother 2004; 53:657-9.
3. Piddock LJ, White DG, Gensberg K, Pumbwe L, Griggs DJ. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44: 3118-21.
4. Ricci V, Piddock LJ. Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J Antimicrob Chemother 2009; 63:909-16.
5. Fabrega A, Sanchez-Cespedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents 2008; 31: 307-15.
6. Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg 2004; 98:423-30.
7. Nikaido H, Pagès JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 2012; 36:340-63.
8. Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, Barrett TJ et al. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 2006; 43: 297-304.
9. Ferrari R, Cremades R, Galiana A, Oliveira T, Rodríguez JC. Mechanisms of resistance to fluoroquinolones in Salmonella spp. Curr Drug Ther 2011; 6: 51-54.
10. Performance standards for antimicrobial susceptibility testing: twenty second informational supplement M100-522. 2012.
11. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L, Fanning S. Multiple regulatori pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteriditis: involvement of ramA and other global regulators. Antimicrob Agents Chemother 2009; 53:1080-7.
12. Bailey AM, Webber MA, Piddock LJ. Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli. Antimicrob Agents Chemother 2006; 50:1071-4.
13. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8.
14. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 2011; 55:921-4.
15. Spengler G, Rodrigues L, Martins A, Martins M, McCusker M, Cerca P et al. Genetic response of Salmonella enterica serotype Enteritidis to thioridazine rendering the organism resistant to the agent. Int J Antimicrob Agents 2012; 39:16-21.
16. Guillier M, Gottesman S, Storz G. Modulating the outer membrane with small RNAs. Genes Dev 2006; 20:2338-48.
17. Singh R, Swick MC, Ledesma KR, Yang Z, Hu M, Zechiedrich L et al. Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coli. Antimicrob Agents Chemother 2012; 56: 1680-5.
18. Meng J, Bai H, Jia M, Hou Z, Xue X, Zhou Y et al. Restoration of antibiotic susceptibility in fluoroquinolone-resistant Escherichia coli by targeting acrB with antisense phosphorothioate oligonucleotide encapsulated in novel anion liposome. J Antibiot (Tokyo) 2012; 65:129-34.
19. Sun Y, Dai M, Hao H, Wang Y, Huang L, Almofti YA et al. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2012; 67:101-10.
20. Kehrenberg C, Cloeckaert A, Klein G. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J Antimicrob Chemother 2009; 64:1175-80.
21. Zheng J, Tian F, Cui S, Song J, Zhao S, Brown EW et al. Differential gene expression by RamA in ciprofloxacin-resistant Salmonella typhimurium. PLoS One 2011; 6:e22161.
22. Abouzeed YM, Baucheron S, Cloeckaert A. RamR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008; 52:2428-34.
23. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E et al. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets 2008; 9:750-9.